US › Healthcare

Bone Biologics Corp (BBLG)

US · Healthcare · Biotechnology

$0.50-7.08%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-773,702

EPS

$-0.43

EPS estimate

$-0.39

EPS came in at -0.43 against a street estimate of -0.39 — a miss of 10.3%.

Key statistics

Market cap

$1.5M

Forward P/E

0.0

P/B

0.39

Book value

$2.17

EPS (TTM)

$-0.28

52-week high

$2.89

52-week low

$0.54

50-day MA

$0.89

200-day MA

$1.28

Beta

0.50

Analyst view

Analysts rate Bone Biologics Corp a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $12.20.

Shareholding

Insiders

0.02%

Institutions

5.01%

Largest institutional holders

Fund	Stake
Citadel Advisors Llc	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Bone Biologics Corp — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.